About Norwegian Medicines Agency
Norwegian Medicines Agency was established 1st January 2001
Norwegian Medicines Agency (NoMA) is an administrative organ covering pharmaceuticals. The Norwegian Medicines Agency directs supervision of production, clinical trials and marketing of pharmaceuticals. It authorises and monitors pharmaceuticals, and will contribute to correct and economical use of pharmaceuticals. The organisation has 210 employees.
From 1st January the different branches of public administration of pharmaceuticals in Norway have become united in the Norwegian Medicines Agency. The former Norwegian Medicines Control Authority, the main section of the department for pharmacies and pharmaceuticals in the National Health Services and parts of the National Insurance Administration comprise the new Norwegian Medicines Agency. The object of this is better organisation of the resources in the pharmaceutical area.
Norwegian Medicines Agency has, among others, the following responsibilities:
- Supervision of manufacture and distribution of pharmaceuticals
- Authorisation of importers of pharmaceuticals
- Supervision of clinical trials
- Supervision of pharmacies
- Classification of pharmaceuticals, management of the drug and doping list
- Marketing authorisation for pharmaceuticals
- Standardisation and pharmaceutical postmarketing control
- Medical postmarketing control, monitoring of adverse drug reactions
- Pricing
- Assessment of pharmaceuticals for authorisation of prescribing on blue prescription forms
- Therapy guidelines and pharmaceutical information
- Norway's representative in EU's pharmaceutical organs
Co-ordination of these tasks will give us a more efficient and comprehensive administration in this area. The new organisation largely corresponds to that which is usual in the rest of Western Europe.
Gro Ramsten Wesenberg
director
Sist gjennomgått: 13.09.2005
Første gang publisert: 04.01.2001